Sabine Charrier

2.9k total citations
38 papers, 1.9k citations indexed

About

Sabine Charrier is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Sabine Charrier has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Molecular Biology and 14 papers in Genetics. Recurrent topics in Sabine Charrier's work include Virus-based gene therapy research (14 papers), CAR-T cell therapy research (11 papers) and RNA Interference and Gene Delivery (8 papers). Sabine Charrier is often cited by papers focused on Virus-based gene therapy research (14 papers), CAR-T cell therapy research (11 papers) and RNA Interference and Gene Delivery (8 papers). Sabine Charrier collaborates with scholars based in France, Germany and United Kingdom. Sabine Charrier's co-authors include Anne Galy, William Vainchenker, Adrian J. Thrasher, Axel Schambach, Juan A. Bueren, J Dauplat, Susana Navarro, Ute Modlich, Daniela Zychlinski and Sabine Knoess and has published in prestigious journals such as Blood, PLoS ONE and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Sabine Charrier

36 papers receiving 1.8k citations

Peers

Sabine Charrier
Kevin T. McDonagh United States
Teresita Díaz de Ståhl Sweden
David DiGiusto United States
Anne I.J. Arens Netherlands
Robert E. Sobol United States
Ajay K. Malik United States
Itamar Goldstein Israel
Sandrine Valsesia‐Wittmann France
Phillip B. Maples United States
Carmel M. Lynch United States
Kevin T. McDonagh United States
Sabine Charrier
Citations per year, relative to Sabine Charrier Sabine Charrier (= 1×) peers Kevin T. McDonagh

Countries citing papers authored by Sabine Charrier

Since Specialization
Citations

This map shows the geographic impact of Sabine Charrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Charrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Charrier more than expected).

Fields of papers citing papers by Sabine Charrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Charrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Charrier. The network helps show where Sabine Charrier may publish in the future.

Co-authorship network of co-authors of Sabine Charrier

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Charrier. A scholar is included among the top collaborators of Sabine Charrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Charrier. Sabine Charrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brendel, Christian, Michael Rothe, Giorgia Santilli, et al.. (2018). Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease. PubMed. 29(2). 69–79. 28 indexed citations
2.
Poletti, Valentina, Sabine Charrier, Guillaume Corre, et al.. (2018). Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency. Molecular Therapy — Methods & Clinical Development. 9. 257–269. 33 indexed citations
3.
Rı́o, Paula, Susana Navarro, Guillermo Güenechea, et al.. (2017). Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients. Blood. 130(13). 1535–1542. 42 indexed citations
4.
Nowrouzi, Ali, M. Luz Lozano, Anne Galy, et al.. (2015). Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs. Current Gene Therapy. 15(6). 550–562. 18 indexed citations
5.
Rivera-Muñoz, Paola, Vincent Abramowski, Serge Jacquot, et al.. (2015). Lymphopoiesis in transgenic mice over-expressing Artemis. Gene Therapy. 23(2). 176–186. 6 indexed citations
6.
Charrier, Sabine, Michael P. Blundell, Fawzia Louache, et al.. (2013). Wiskott-Aldrich syndrome protein-deficient hematopoietic cells can be efficiently mobilized by granulocyte colony-stimulating factor. Haematologica. 98(8). 1300–1308. 6 indexed citations
7.
Capron, Claude, Catherine Lacout, Yann Lécluse, et al.. (2010). A major role of TGF-β1 in the homing capacities of murine hematopoietic stem cell/progenitors. Blood. 116(8). 1244–1253. 31 indexed citations
8.
Charrier, Sabine, Marina Ferrand, Guillaume Précigout, et al.. (2010). Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction. Gene Therapy. 18(5). 479–487. 72 indexed citations
9.
Charrier, Sabine, Ralph Eckenberg, William Saurin, et al.. (2009). Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott–Aldrich syndrome. The Journal of Gene Medicine. 11(8). 645–654. 13 indexed citations
10.
Charrier, Sabine, Susan S. Martin, Paule Opolon, et al.. (2009). Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS. Gene Therapy. 16(5). 605–619. 58 indexed citations
11.
Modlich, Ute, Susana Navarro, Daniela Zychlinski, et al.. (2009). Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors. Molecular Therapy. 17(11). 1919–1928. 289 indexed citations
12.
Charrier, Sabine, Loı̈c Dupré, Samantha Scaramuzza, et al.. (2006). Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients. Gene Therapy. 14(5). 415–428. 79 indexed citations
13.
Olivier, Aurélie, Laurence Jeanson-Leh, Gerben Bouma, et al.. (2005). A Partial Down-regulation of WASP Is Sufficient to Inhibit Podosome Formation in Dendritic Cells. Molecular Therapy. 13(4). 729–737. 39 indexed citations
14.
Proust, Alexis, Benoît Guillet, Isabelle Pellier, et al.. (2005). Recurrent V75M mutation within the Wiskott–Aldrich syndrome protein: description of a homozygous female patient. European Journal Of Haematology. 75(1). 54–59. 7 indexed citations
15.
Charrier, Sabine, Daniel Stockholm, Paule Opolon, et al.. (2004). A lentiviral vector encoding the human Wiskott–Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Therapy. 12(7). 597–606. 98 indexed citations
16.
Coppo, Paul, A Bussel, Sabine Charrier, et al.. (2003). High-Dose Plasma Infusion versus Plasma Exchange as Early Treatment of Thrombotic Thrombocytopenic Purpura/Hemolytic-Uremic Syndrome. Medicine. 82(1). 27–38. 82 indexed citations
17.
Boiret, Nathalie, Chantal Rapatel, Stéphane Boisgard, et al.. (2003). CD34+CDw90(Thy-1)+ subset colocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony-forming unit megakaryocytes and long-term culture-initiating cells. Experimental Hematology. 31(12). 1275–1283. 19 indexed citations
18.
Charrier, Sabine, P. Chollet, J.-O. Bay, et al.. (2000). Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancer. Bone Marrow Transplantation. 25(7). 705–710. 2 indexed citations
19.
Kwiatkowski, Fabrice, et al.. (1999). Chrono-pharmacocinétique du 5-fluoro-uracile dans le traitement des cancers colorectaux métastatiques et indicateurs de réponse métabolique. Journal de Pharmacie Clinique. 18(2). 138–143. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin T. McDonagh Breakdown of academic impact, for papers by Teresita Díaz de Ståhl Breakdown of academic impact, for papers by David DiGiusto Breakdown of academic impact, for papers by Anne I.J. Arens Breakdown of academic impact, for papers by Robert E. Sobol Breakdown of academic impact, for papers by Ajay K. Malik Breakdown of academic impact, for papers by Itamar Goldstein Breakdown of academic impact, for papers by Sandrine Valsesia‐Wittmann Breakdown of academic impact, for papers by Phillip B. Maples Breakdown of academic impact, for papers by Carmel M. Lynch
Rankless by CCL
2026